DS
CLPT icon

David Shaw’s ClearPoint Neuro CLPT Stock Holding History

David Shaw’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-289,823
Closed -$3.46M – 4600
2025
Q2 		$3.46M Buy
289,823
+24,141
+9% +$304K ﹤0.01% 2312
2025
Q1 		$3.16M Sell
265,682
-22,727
-8% -$353K ﹤0.01% 2257
2024
Q4 		$4.44M Buy
288,409
+62,889
+28% +$815K ﹤0.01% 2076
2024
Q3 		$2.53M Buy
225,520
+146,489
+185% +$1.4M ﹤0.01% 2522
2024
Q2 		$426K Buy
79,031
+37,416
+90% +$217K ﹤0.01% 3725
2024
Q1 		$283K Buy
+41,615
New +$291K ﹤0.01% 3755
2023
Q3 		– Sell
-25,973
Closed -$188K – 4286
2023
Q2 		$188K Buy
+25,973
New +$221K ﹤0.01% 3754

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $428M AUM 136.02% 1-Year Est. Return

David Shaw's CLPT Position: Q3 2025 in Review

David Shaw sold out of ClearPoint Neuro (CLPT) in Q3 2025, closing a stake of 289,823 shares — an estimated $3.46M sold.

David Shaw first reported a position in CLPT in Q2 2023 and held it in 7 quarters. The position peaked at $4.44M in Q4 2024. 107 funds tracked by Wall St. Rank hold CLPT as of Q3 2025.

  • David Shaw reported no remaining ClearPoint Neuro position as of Q3 2025 after selling out during the quarter.
  • David Shaw sold 289,823 ClearPoint Neuro shares in Q3 2025, an estimated $3.46M.
  • David Shaw first reported a position in ClearPoint Neuro in Q2 2023 and held it in 7 quarters.
  • David Shaw's ClearPoint Neuro position peaked at $4.44M in Q4 2024.
  • 107 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2025.

Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.